# DESCRIPTION

## FIELD OF THE INVENTION

- introduce eukaryotic cell reprogramming and Neural Stem-Like Cells (NSLCs)

## Cell Reprogramming

- motivate cell reprogramming
- describe limitations of current reprogramming methods
- summarize prior art on cell reprogramming
- highlight need for true reprogramming
- introduce induced pluripotent stem cells (iPS cells)
- describe need for multipotent stem cells

## SUMMARY OF THE INVENTION

- introduce stem-like and progenitor-like cells
- motivate cell dedifferentiation and reprogramming
- describe compositions and methods for reprogramming cells
- outline method of transforming cell of first type to cell of different type
- describe method of obtaining Stem-Like Cell (SLC)
- describe method of obtaining Neural Stem-Like Cell (NSLC)
- outline use of isolated cells, cell lines, compositions, and tissues for medical treatment

## DETAILED DESCRIPTION OF THE INVENTION

- introduce cell dedifferentiation and reprogramming methods

### Definitions

- define singular forms
- define key terms in invention
- define cell-related terms

### Cell Transformation

- define cell transformation and reprogramming
- explain dedifferentiation and transdifferentiation
- define somatic cells and stem cells
- describe method of transforming a cell of a first type to a cell of a second different type
- outline steps of transformation method
- define reprogramming agent and gene regulator
- explain conditions supporting growth and transformation
- provide examples of reprogramming agents and gene regulators
- define key terms
- describe cell transformation method
- explain chromatin and/or DNA remodeling
- discuss reprogramming agents and their functions
- outline additional steps for facilitating cell reprogramming

### Obtaining Neural Stem-Like Cells (NSLCs)

- introduce NSLCs and their potential for neurological therapies
- motivate reprogramming of somatic cells to NSLCs
- describe method of obtaining NSLCs using neural stem cell regulating polypeptides
- describe method of obtaining NSLCs using histone acetylators and DNA demethylators
- detail reprogramming agents and their use in generating NSLCs
- describe use of DNA expression vectors in reprogramming somatic cells
- outline method for generating NSLCs by introducing genetically-engineered DNA sequence
- describe differentiation of NSLCs into neuronal and glial cells
- discuss selection and characterization of reprogrammed cells
- outline delivery of polynucleotides for reprogramming somatic cells
- introduce obtaining neural stem-like cells (NSLCs)
- describe delivery of polypeptides
- discuss cells and cell lines
- outline characteristics of NSLCs
- describe production of tissue-specific autologous stem and/or progenitor cells
- discuss therapeutic methods and methods of treatment
- describe tissues
- outline screening methods
- discuss delivery of neurotrophic factors
- summarize the invention

## EXAMPLES

- provide exemplary methods for obtaining Reprogrammed and Dedifferentiated cells

### Example I

- prepare human fibroblast cells
- transiently transfect HFF by lipofectamine using constructed vectors
- perform gene array analysis
- analyze gene expression and protein levels
- perform immunohistochemical analysis

### Example II

- compare reprogramming efficiency of three different neurogenic genes

### Example III

- test various combinations of vectors and disruption of cell cytoskeleton
- perform gene expression analysis
- perform immunohistochemical analysis
- test various DNA demethylators
- perform gene array analysis
- analyze reprogrammed cells for neural stem-like cell morphology

### Example IV

- compare Nucleofector™ II Device and Nucleofector™ 96-well Shuttle Device
- analyze Sox2 positive cells with neural stem cell morphology

### Example V

- design neurosphere formation assay
- transfect HFFs with Msi1/Ngn2 vector
- analyze gene expression of reprogrammed cells
- perform immunohistochemistry analysis of neurospheres
- quantify adherent population of NSLCs
- perform gene expression microarray analysis
- analyze up-regulation of neural precursor genes
- investigate differentiation potential of NSLCs
- characterize differentiated cells using neuronal markers

### Example VI

- evaluate role of Noggin in reprogramming of HFFs

### Example VII

- differentiate NSLCs towards adipocyte cells to distinguish from SKPs

### Example VIII

- demonstrate BDNF release from NLCs

### Example IX

- prepare human CD34+, ADSC, and keratinocytes
- transfect cells with Msi1-Ngn2 and analyze for neural stem cell markers
- quantify reprogrammed cells and analyze gene expression profiles
- perform immunohistochemistry and analyze neural stem cell markers
- test NSLCs for tripotent capacity and differentiate towards neuronal lineage
- analyze differentiated cells for neural markers and gene expression
- compare NSLCs generated from different cell types
- describe gene expression analysis
- motivate reprogramming of cells
- describe transfection and nucleofection methods
- analyze telomerase activity
- perform tumor formation assay
- summarize reprogramming results
- perform Southern blot analysis
- describe animal model of multiple sclerosis
- outline treatment of EAE animal model
- describe hemiplegic animal model
- transfect HFF cells with various gene combinations
- describe reprogramming of HFFs into pancreatic progenitor-like cells
- describe reprogramming of ADSCs into pluripotent-like stem cells
- investigate effect of pEF-Rex1-EF-Oct4-2A-Klf4-2A-RFP on reprogramming efficiency
- test various genes for their effect on reprogramming efficiency towards pluripotent-like cells
- describe reprogramming efficiency of defined pluripotency factors on HFF after triple transfection
- reprogram NSLCs into pluripotency
- describe teratoma formation assay in SCID mice
- analyze results of teratoma formation assay

